Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 76

1.

Clinic-Based Urinary Lipoarabinomannan as a Biomarker of Clinical Disease Severity and Mortality Among Antiretroviral Therapy-Naive Human Immunodeficiency Virus-Infected Adults in South Africa.

Drain PK, Losina E, Coleman SM, Giddy J, Ross D, Katz JN, Freedberg KA, Bassett IV.

Open Forum Infect Dis. 2017 Aug 14;4(3):ofx167. doi: 10.1093/ofid/ofx167. eCollection 2017 Summer.

2.

Barriers to Care and 1-Year Mortality Among Newly Diagnosed HIV-Infected People in Durban, South Africa.

Bassett IV, Coleman SM, Giddy J, Bogart LM, Chaisson CE, Ross D, Flash MJ, Govender T, Walensky RP, Freedberg KA, Losina E.

J Acquir Immune Defic Syndr. 2017 Apr 1;74(4):432-438. doi: 10.1097/QAI.0000000000001277.

3.

Rapid urine lipoarabinomannan assay as a clinic-based screening test for active tuberculosis at HIV diagnosis.

Drain PK, Losina E, Coleman SM, Giddy J, Ross D, Katz JN, Bassett IV.

BMC Pulm Med. 2016 Nov 14;16(1):147.

4.

BioVeL: a virtual laboratory for data analysis and modelling in biodiversity science and ecology.

Hardisty AR, Bacall F, Beard N, Balcázar-Vargas MP, Balech B, Barcza Z, Bourlat SJ, De Giovanni R, de Jong Y, De Leo F, Dobor L, Donvito G, Fellows D, Guerra AF, Ferreira N, Fetyukova Y, Fosso B, Giddy J, Goble C, Güntsch A, Haines R, Ernst VH, Hettling H, Hidy D, Horváth F, Ittzés D, Ittzés P, Jones A, Kottmann R, Kulawik R, Leidenberger S, Lyytikäinen-Saarenmaa P, Mathew C, Morrison N, Nenadic A, de la Hidalga AN, Obst M, Oostermeijer G, Paymal E, Pesole G, Pinto S, Poigné A, Fernandez FQ, Santamaria M, Saarenmaa H, Sipos G, Sylla KH, Tähtinen M, Vicario S, Vos RA, Williams AR, Yilmaz P.

BMC Ecol. 2016 Oct 20;16(1):49.

5.

Sizanani: A Randomized Trial of Health System Navigators to Improve Linkage to HIV and TB Care in South Africa.

Bassett IV, Coleman SM, Giddy J, Bogart LM, Chaisson CE, Ross D, Jacobsen MM, Robine M, Govender T, Freedberg KA, Katz JN, Walensky RP, Losina E.

J Acquir Immune Defic Syndr. 2016 Oct 1;73(2):154-60. doi: 10.1097/QAI.0000000000001025.

6.

Optimal timing of antiretroviral treatment initiation in HIV-positive children and adolescents: a multiregional analysis from Southern Africa, West Africa and Europe.

Schomaker M, Leroy V, Wolfs T, Technau KG, Renner L, Judd A, Sawry S, Amorissani-Folquet M, Noguera-Julian A, Tanser F, Eboua F, Navarro ML, Chimbetete C, Amani-Bosse C, Warszawski J, Phiri S, N'Gbeche S, Cox V, Koueta F, Giddy J, Sygnaté-Sy H, Raben D, Chêne G, Davies MA; IeDEA West and Southern Africa regional collaborations and COHERE in EuroCoord.

Int J Epidemiol. 2017 Apr 1;46(2):453-465. doi: 10.1093/ije/dyw097.

PMID:
27342220
7.

Cervical Abnormalities in South African Women Living With HIV With High Screening and Referral Rates.

Katz IT, Butler LM, Crankshaw TL, Wright AA, Bramhill K, Leone DA, Giddy J, Mould S.

J Glob Oncol. 2016 May 4;2(6):375-380. doi: 10.1200/JGO.2015.002469. eCollection 2016 Dec.

8.

Record linkage to correct under-ascertainment of cancers in HIV cohorts: The Sinikithemba HIV clinic linkage project.

Sengayi M, Spoerri A, Egger M, Kielkowski D, Crankshaw T, Cloete C, Giddy J, Bohlius J.

Int J Cancer. 2016 Sep 15;139(6):1209-16. doi: 10.1002/ijc.30154. Epub 2016 May 18.

9.

Growth of HIV-Exposed Uninfected Infants in the First 6 Months of Life in South Africa: The IeDEA-SA Collaboration.

Morden E, Technau KG, Giddy J, Maxwell N, Keiser O, Davies MA.

PLoS One. 2016 Apr 6;11(4):e0151762. doi: 10.1371/journal.pone.0151762. eCollection 2016.

10.

Growth and Mortality Outcomes for Different Antiretroviral Therapy Initiation Criteria in Children Ages 1-5 Years: A Causal Modeling Analysis.

Schomaker M, Davies MA, Malateste K, Renner L, Sawry S, N'Gbeche S, Technau KG, Eboua F, Tanser F, Sygnaté-Sy H, Phiri S, Amorissani-Folquet M, Cox V, Koueta F, Chimbete C, Lawson-Evi A, Giddy J, Amani-Bosse C, Wood R, Egger M, Leroy V; IeDEA West Africa and IeDEA Southern Africa collaboration.

Epidemiology. 2016 Mar;27(2):237-46. doi: 10.1097/EDE.0000000000000412.

11.

Implementation and Operational Research: Risk Charts to Guide Targeted HIV-1 Viral Load Monitoring of ART: Development and Validation in Patients From Resource-Limited Settings.

Koller M, Fatti G, Chi BH, Keiser O, Hoffmann CJ, Wood R, Prozesky H, Stinson K, Giddy J, Mutevedzi P, Fox MP, Law M, Boulle A, Egger M.

J Acquir Immune Defic Syndr. 2015 Nov 1;70(3):e110-9. doi: 10.1097/QAI.0000000000000748.

12.

Age in antiretroviral therapy programmes in South Africa: a retrospective, multicentre, observational cohort study.

Cornell M, Johnson LF, Schomaker M, Tanser F, Maskew M, Wood R, Prozesky H, Giddy J, Stinson K, Egger M, Boulle A, Myer L; International Epidemiologic Databases to Evaluate AIDS-Southern Africa Collaboration.

Lancet HIV. 2015 Sep;2(9):e368-75. doi: 10.1016/S2352-3018(15)00113-7. Epub 2015 Aug 4.

13.

Reducing CD4 Monitoring in Children on Antiretroviral Therapy With Virologic Suppression.

Davies MA, Ford N, Rabie H, Fatti G, Stinson K, Giddy J, Tanser F, Technau KG, Sawry S, Eley B, Wood R, Mofenson LM, Keiser O, Boulle A.

Pediatr Infect Dis J. 2015 Dec;34(12):1361-4. doi: 10.1097/INF.0000000000000912.

14.

Understanding HIV-infected patients' experiences with PEPFAR-associated transitions at a Centre of Excellence in KwaZulu Natal, South Africa: a qualitative study.

Katz IT, Bogart LM, Cloete C, Crankshaw TL, Giddy J, Govender T, Gaynes MR, Leone D, Losina E, Bassett IV.

AIDS Care. 2015;27(10):1298-303. doi: 10.1080/09540121.2015.1051502. Epub 2015 Aug 24.

15.

Social support and mental health among adults prior to HIV counseling and testing in Durban, South Africa.

Drain PK, Losina E, Coleman SM, Bogart L, Giddy J, Ross D, Katz JN, Bassett IV.

AIDS Care. 2015;27(10):1231-40. doi: 10.1080/09540121.2015.1046417. Epub 2015 Jul 25.

16.

Growth in Virologically Suppressed HIV-Positive Children on Antiretroviral Therapy: Individual and Population-level References.

Keiser O, Blaser N, Davies MA, Wessa P, Eley B, Moultrie H, Rabie H, Technau KG, Ndirangu J, Garone D, Giddy J, Grimwood A, Gsponer T, Egger M; for IeDEA Southern Africa.

Pediatr Infect Dis J. 2015 Oct;34(10):e254-9. doi: 10.1097/INF.0000000000000801.

17.

Outcomes of Infants Starting Antiretroviral Therapy in Southern Africa, 2004-2012.

Porter M, Davies MA, Mapani MK, Rabie H, Phiri S, Nuttall J, Fairlie L, Technau KG, Stinson K, Wood R, Wellington M, Haas AD, Giddy J, Tanser F, Eley B.

J Acquir Immune Defic Syndr. 2015 Aug 15;69(5):593-601. doi: 10.1097/QAI.0000000000000683.

18.

Prevalence of cryptococcal antigenuria at initial HIV diagnosis in KwaZulu-Natal.

Drain PK, Kleene JM, Coleman SM, Losina E, Katz JN, Giddy J, Ross D, Freedberg KA, Bassett IV.

HIV Med. 2015 Nov;16(10):640-4. doi: 10.1111/hiv.12263. Epub 2015 May 11.

19.

Pregnant women's experiences of male partner involvement in the context of prevention of mother-to-child transmission in Khayelitsha, South Africa.

Brittain K, Giddy J, Myer L, Cooper D, Harries J, Stinson K.

AIDS Care. 2015;27(8):1020-4. doi: 10.1080/09540121.2015.1018862. Epub 2015 Mar 4.

PMID:
25738960
20.

The Linkage Outcomes of a Large-scale, Rapid Transfer of HIV-infected Patients From Hospital-based to Community-based Clinics in South Africa.

Cloete C, Regan S, Giddy J, Govender T, Erlwanger A, Gaynes MR, Freedberg KA, Katz JN, Walensky RP, Losina E, Bassett IV.

Open Forum Infect Dis. 2014 Aug 12;1(2):ofu058. doi: 10.1093/ofid/ofu058. eCollection 2014 Sep.

Supplemental Content

Support Center